http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09502711-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H04N5-64 |
| filingDate | 1994-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H09502711-A |
| titleOfInvention | 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide-3-carboxylic acid derivatives, their preparation and agents containing them |
| abstract | (57) [Summary] R 1 is carboxyl, alkoxycarbonyl, tetrazolyl, -CO-NH 2, -CO- NH-alk, -CO-N (alk) 2, -CO-NHOH, -CO-N (alk) OH, -CO-NH -O-R 10, shows a -CO-N (alk) -OR 10 group, or in vivo in groups which can be converted into a carboxy group, R 2, R 3 and R 4 are identical or different and represent hydrogen or a halogen atom or an alkyl or alkoxy group,, R 5 represents hydroxyl, -NHOH, -NH-CO-NH 2, -CH 2 -NH 2, hydroxyalkyl, alkoxyalkyl or -alk = NOH group, R 6 , R 7 , R 8 and R 9 are the same or different and are hydrogen or a halogen atom, or alkyl, alkoxy, polyfluoroalkyl, amino, nitro, cyano, phenyl, bi Cycloalkenyl, polyfluoroalkoxy, alkoxycarbonyl, carboxyl, phenyl alkyloxy, phenylalkyl, benzoylamino, phenyl carbonyl, hydroxy, -NHOH, -NH-CO-NH 2, -CH 2 -NH 2, hydroxyalkyl, alkoxyalkyl, -Alk = NOH or phenoxy group, the phenyl ring may be optionally substituted by a halogen atom and one or several substituents selected from alkyl, alkoxy or polyfluoroalkyl groups, wherein R 10 is alkyl. Or a compound of formula (I), which represents a phenylalkyl group, wherein alk represents an alkyl or alkylene group. The invention also relates to their salts, their manufacture and the medicaments containing them. |
| priorityDate | 1993-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.